These findings increase our understanding about the role of NK cells in shaping tumour adaptive immune response and support previous results indicating that NK cells drive inflammation and immune cell infiltration, including conventional type 1 Dendritic Cells (cDC1), increasing tumour neoantigen presentation and CD8+ T cell immunity (141–144). This evidence concerns the gene CD8A and neoplasm.